{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:26:06Z","timestamp":1790961966408,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21873057"],"award-info":[{"award-number":["21873057"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2016HM02"],"award-info":[{"award-number":["ZR2016HM02"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2019MB041"],"award-info":[{"award-number":["ZR2019MB041"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014417","name":"Fundamental Research Fund of Shandong University","doi-asserted-by":"publisher","award":["2018JC006"],"award-info":[{"award-number":["2018JC006"]}],"id":[{"id":"10.13039\/100014417","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jconrel.2022.04.041","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T07:12:00Z","timestamp":1651648320000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Combination of oxaliplatin and POM-1 by nanoliposomes to reprogram the tumor immune microenvironment"],"prefix":"10.1016","volume":"347","author":[{"given":"Xianglei","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengchang","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyang","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yankun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.04.041_bb0005","first-page":"620","article-title":"Smart nanovesicle-mediated immunogenic cell death through tumor microenvironment modulation for effective photodynamic immunotherapy","volume":"14","author":"Yang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0010","first-page":"8333","article-title":"Sustained delivery of carfilzomib by tannic acid-based nanocapsules helps develop antitumor immunity","volume":"19","author":"Taha","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0015","article-title":"Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer","volume":"8","author":"Arai","year":"2020","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0020","article-title":"ATP-responsive smart hydrogel releasing immune adjuvant synchronized with repeated chemotherapy or radiotherapy to boost antitumor immunity","volume":"33","author":"Sun","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0025","first-page":"10","article-title":"Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma","volume":"20","author":"Guo","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0030","first-page":"505","article-title":"Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death","volume":"337","author":"Banstola","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0035","first-page":"306","article-title":"Low dose shikonin and anthracyclines coloaded liposomes induce robust immunogenetic cell death for synergistic chemo-immunotherapy","volume":"335","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0040","first-page":"448","article-title":"Oxygen and oxaliplatin-loaded nanoparticles combined with photo-sonodynamic inducing enhanced immunogenic cell death in syngeneic mouse models of ovarian cancer","volume":"332","author":"Zheng","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0045","first-page":"1","article-title":"The inducers of immunogenic cell death for tumor immunotherapy","volume":"104","author":"Li","year":"2017","journal-title":"Tumori"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0050","first-page":"369","article-title":"Novel \u2018stereoscopic response\u2019 strategy can be used in combination therapy","volume":"35","author":"Gu","year":"2018","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0055","first-page":"1838036","article-title":"Fully human anti-CD39 antibody potently inhibits ATPase activity in cancer cells via uncompetitive allosteric mechanism","volume":"12","author":"Spatola","year":"2020","journal-title":"MAbs"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0060","first-page":"74","article-title":"Dormant tumor cells interact with memory CD8+ T cells in RET transgenic mouse melanoma model","volume":"474","author":"Flores-Guzm\u00e1n","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0065","first-page":"2411","article-title":"Blocking antibodies targeting the CD39\/CD73 immunosuppressive pathway unleash immune responses in combination Cancer therapies","volume":"27","author":"Perrot","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0070","first-page":"57","article-title":"Targeting adenosine for cancer immunotherapy","volume":"6","author":"Leone","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0075","first-page":"115","article-title":"CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells","volume":"78","author":"Canale","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0080","first-page":"136","article-title":"Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells","volume":"6","author":"Wang","year":"2018","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0085","first-page":"393","article-title":"Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39","volume":"1","author":"Michaud","year":"2012","journal-title":"OncoImmunology"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0090","first-page":"4755","article-title":"Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles","volume":"12","author":"Qi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0095","first-page":"53","article-title":"Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future","volume":"15","author":"Huang","year":"2019","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0100","first-page":"107","article-title":"Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function","volume":"35","author":"Nagate","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0105","first-page":"4089","article-title":"Single-cell profiles and prognostic impact of tumor-infiltrating lymphocytes coexpressing CD39, CD103, and PD-1 in ovarian cancer","volume":"27","author":"Laumont","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0110","first-page":"1251","article-title":"The novel NTPDase inhibitor sodium polyoxotungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition","volume":"55","author":"Wall","year":"2008","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0115","article-title":"On the mechanism of anti-CD39 immune checkpoint therapy","volume":"8","author":"Allard","year":"2020","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0120","first-page":"731","article-title":"Extracellular ATP and adenosine in cancer pathogenesis and treatment, trends","volume":"7","author":"Chiarella","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0125","first-page":"509","article-title":"Conversion of extracellular ATP into adenosine: a master switch in renal health and disease","volume":"16","author":"Dwyer","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0130","first-page":"G200","article-title":"Synapomorphic features of hepatic and pulmonary vasculatures include comparable purinergic signaling responses in host defense and modulation of inflammation","volume":"321","author":"Hanidziar","year":"2021","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0135","first-page":"202","article-title":"Relevance of tumor-infiltrating lymphocytes in breast cancer","volume":"13","author":"Dushyanthen","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0140","first-page":"175","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0145","article-title":"Nanomedicine at the crossroads \u2013 a quick guide for ivivc","volume":"113829","author":"Mast","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0150","article-title":"Tumor microenvironment-activatable prodrug vesicles for nanoenabled cancer chemoimmunotherapy combining immunogenic cell death induction and CD47 blockade","volume":"31","author":"Zhou","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0155","first-page":"1160","article-title":"Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas, neuro","volume":"15","author":"Xu","year":"2013","journal-title":"Oncol."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0160","first-page":"418","article-title":"Cytokines and costimulation in acute graft-versus-host disease","volume":"136","author":"Hill","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0165","first-page":"83","article-title":"Cytokines in the treatment of melanoma","volume":"23","author":"Bentebibel","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0170","first-page":"417","article-title":"Negative feedback control of neuronal activity by microglia","volume":"586","author":"Badimon","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0175","first-page":"2195","article-title":"Differences in nanoparticle uptake in transplanted and autochthonous models of pancreatic cancer","volume":"18","author":"Tao","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0180","article-title":"Oxaliplatin-\/NLG919 prodrugs-constructed liposomes for effective chemo-immunotherapy of colorectal cancer","volume":"255","author":"Shen","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0185","first-page":"369","article-title":"Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity","volume":"286","author":"Gu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0190","first-page":"1666","article-title":"High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model","volume":"117","author":"Luchtel","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0195","first-page":"1053","article-title":"Proton-driven transformable nanovaccine for cancer immunotherapy","volume":"15","author":"Gong","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0200","first-page":"1754","article-title":"Targeting CD39 in cancer reveals an extracellular ATP-and inflammasome-driven tumor immunity","volume":"9","author":"Li","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0205","first-page":"24","article-title":"Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8+ T cell responses","volume":"191","author":"Keller","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0210","article-title":"Dichotomous and stable gamma delta T-cell number and function in healthy individuals","volume":"9","author":"Ou","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2022.04.041_bb0215","first-page":"971","article-title":"Melanoma","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0220","first-page":"eabb3116","article-title":"A tumor-to-lymph procedure navigated versatile gel system for combinatorial therapy against tumor recurrence and metastasis","volume":"6","author":"Qin","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2022.04.041_bb0225","first-page":"1043","article-title":"A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy","volume":"15","author":"Xu","year":"2020","journal-title":"Nat. Nanotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922002371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922002371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:15:40Z","timestamp":1759162540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922002371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":45,"alternative-id":["S0168365922002371"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.04.041","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of oxaliplatin and POM-1 by nanoliposomes to reprogram the tumor immune microenvironment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.04.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}